Try For Free 7-Day Free Trial
LabCorp of America Holdings is a provider of medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp was formed in 1971 and is based in Burlington, North Carolina.
|Overall||15 of 41|
|Sector (Life Science)||10 of 20|
|Type (Divestiture)||1 of 13|
|State (Massachusetts)||1 of 4|
|Country (United States)||15 of 39|
|Year (2010)||2 of 2|
|Size (of disclosed)||3 of 13|
DCL Medical laboratories LLC
Indianapolis, Indiana, United States
DCL Medical laboratories LLC, a women's health-focused laboratory, provides diagnostic and clinical trial testing to physicians, hospitals and pharmaceutical companies throughout the central Midwest.
Clearstone Central Laboratories, Inc.
Mississauga, Ontario, Canada
Clearstone Central Laboratories, Inc., is a provider of central laboratory services for late-stage clinical trials.
Genzyme is a global biotech company. Genzyme's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease. Genzyme was formed in 1981 and is based in Cambridge, Massachusetts.
|Overall||2 of 3|
|Sector (Life Science)||1 of 1|
|Type (Divestiture)||2 of 3|
|State (Massachusetts)||1 of 1|
|Country (United States)||2 of 2|
|Year (2010)||2 of 2|
|Size (of disclosed)||1 of 3|
Genzyme Corporation’s Diagnostic Product Division
Genzyme Diagnostics is a leading provider of global diagnostic products for diagnostics manufacturers, clinical laboratories and physician offices. Sekisui acquired facilities in the U.S., Canada, Germany and the U.K.
Genzyme Corp -Cholestagel(R)
Genzyme Corp -Cholestagel(R) Colesevelam is a bile acid sequestrant administered orally. Cholestagel(R) is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container. Cholestagel(R) is contraindicated in patients with bowel or biliary obstruction. Cholestagel(R) is contraindicated in patients with serum triglyceride (TG) > 500 mg/dL and in patients with a history of hypertiglyceridemia-induced pancreatitis.